VALERIO THERAPEUTICS
LIVE

Serial Number

97867242

Owner

VALERIO THERAPEUTICS

Attorney

Ben Natter

Filing Date

Mar 31, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VALERIO THERAPEUTICS Trademark

Serial Number: 97867242 • Registration: 7574311

VALERIO THERAPEUTICS is a trademark filed by VALERIO THERAPEUTICS on March 31, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

VALERIO THERAPEUTICS (2 trademarks)

49 BOULEVARD DU GÉNÉRAL MARTIAL VALIN
PARIS 75015 , FR

Entity Type: 33

ONXEO (26 trademarks)

49 boulevard du Général

Entity Type: 99

Trademark Details

Filing Date

March 31, 2023

Registration Date

November 19, 2024

Goods & Services

Pharmaceutical preparations and substances for the treatment of oncological diseases and related immune disorders; Biological preparations for use in medicinal tests for identifying and treating oncological diseases, inoculations being vaccines, and treatment of oncological diseases; medicinal and biological preparations for pharmaceutical use for the treatment of oncological diseases and disorders; Anti-cancer drugs; Pharmaceutical compounds for treating cancer; Anti-cancer preparations; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Immunoassay reagents for medical use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders

medical analysis services for cancer diagnosis and prognosis; Providing cancer screening services; Medical analysis services for the diagnosis of cancer

Scientific, medical and pharmaceutical research for the treatment of oncological diseases; research and development of pharmaceutical preparations in the field of oncological diseases and disorders; drug discovery services for the treatment of oncological and immune related diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Pharmaceutical products development; Clinical research in the field of oncology; Provision of information and data relating to medical research and development of pharmaceutical products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 19, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Nov 19, 2024 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Oct 7, 2024 CNTA
EXAMINER'S AMENDMENT ENTERED
Oct 7, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 7, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 7, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 7, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 13, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2024 CRFA
ASSIGNED TO LIE
Aug 2, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 16, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 2, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 2, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 2, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 26, 2023 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2023 NWOS
NEW APPLICATION ENTERED
Apr 4, 2023 NWAP